CD177 and cancer: Furthermore, CD177 expression on neutrophils, epithelial cells, and regulatory T cells in solid tumors has been associated with tumor invasion, disease stage, therapeutic responses, and patient survival in various cancers, including gastric, breast, and colorectal cancer (CRC).